Nicklas Westerholm

Filings at 2 companies/Chief executive officer · Egetis Therapeutics AB (publ)

5 of 6 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 6. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 6 visible filings, newest first.

Egetis Therapeutics AB (publ) Chief executive officer
61,155 SEKOpen-market buy
TradedJun 5, 2025FiledJun 10, 2025
Egetis Therapeutics AB (publ) Chief executive officer
43,104 SEKOpen-market buy
TradedOct 7, 2024FiledOct 7, 2024
Spago Nanomedical AB (publ) Board member
12,833 SEKOption exercise
TradedMay 30, 2024FiledMay 31, 2024
Egetis Therapeutics AB (publ) Chief executive officer
119,560 SEKOpen-market buy
TradedFeb 23, 2024FiledFeb 23, 2024
Egetis Therapeutics AB (publ) Chief executive officer
60,633 SEKOpen-market buy
TradedJul 4, 2023FiledJul 4, 2023